Arterial and venous thrombosis and pro - thrombotic fibrin clot phenotype in a Polish family with type 1 antithrombin deficiency (antithrombin krakow)

Thrombosis and Haemostasis

Volumn 106, Issue 2, 2011, Pages 379-381

  Celinska Lowenhoff, Magdalena ^a   Iwaniec, Teresa ^a   Alhenc Gelas, Martine ^b   Musial, Jacek ^a   Undas, Anetta ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; ENOXAPARIN;

ADULT; ANTITHROMBIN DEFICIENCY; ARTERY THROMBOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYANOSIS; DEEP VEIN THROMBOSIS; ECHOGRAPHY; EXON; FAMILY; FEMALE; FIBRIN CLOT; GENE DELETION; HUMAN; ILIAC ARTERY OBSTRUCTION; LETTER; LUNG EMBOLISM; MALE; PHENOTYPE; POLAND; PRIORITY JOURNAL; STOP CODON; VEIN THROMBOSIS;

ADULT; ANTITHROMBIN III; ANTITHROMBIN III DEFICIENCY; BLOOD COAGULATION; CODON, NONSENSE; FEMALE; FIBRIN; HUMANS; INFANT, NEWBORN; MALE; PEDIGREE; PHENOTYPE; POLAND; PREGNANCY; THROMBOSIS; VENOUS THROMBOSIS;

EID: 79961046359     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH11-02-0066     Document Type: Letter

References (16)

1. Patnaik MM, Moll S. Inherited antithrombin deficiency: a review. Haemophilia 2008; 14: 1229-1239.
2. Sharpe CJ, Crowther MA, Webert KE, et al. Cerebral Venous Thrombosis During Pregnancy in the Setting of Type I Antithrombin Deficiency: Case Report and Literature Review. Transfus Med Rev 2011; 25: 61-65.
3. Lane DA, Bayston T, Olds RJ, et al. Antithrombin mutation database: 2nd (1997) update. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1997; 77: 197-211.
4. Picard V, Chen JM, Tardy B, et al. Detection and characterization of large SERPINC1 deletions in type I inherited antithrombin deficiency. Hum Genet 2010; 127: 45-53.
5. Finazzi G, Caccia R, Barbui T. Different prevalence of thromboembolism in the subtypes of congenital antithrombin III deficiency: review of 404 cases. Thromb Haemost 1987; 18: 1094.
6. Picard V, Nowak-Göttl U, Biron-Andreani C, et al. Molecular bases of antithrombin deficiency: twenty- two novel mutations in the antithrombin gene. Hum Mutat 2006; 27: 600.
7. Undas A, Zawilska K, Ciesla-Dul M, et al. Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives. Blood 2009; 114: 4272-4278.
8. Lisman T, de Groot PG, Meijers JCM, et al. Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis. Blood 2005; 15: 1102-1105.
9. Wolf M, Boyer C, Tripodi A, et al. Antithrombin Milano: A new variant with monomeric and dimeric inactive antithrombin III. Blood 1985; 65: 496-500.
10. Scott EM, Ariëns RA, Grant PJ. Genetic and environmental determinants of fibrin structure and function: relevance to clinical disease. Arterioscler Thromb Vasc Biol 2004; 24: 1558-1566.
11. Wolberg AS. Thrombin generation and fibrin clot structure. Blood Rev 2007; 21: 131-142.
12. Campbell RA, Overmyer KA, Bagnell R, et al. Cellular procoagulant activity dictates clot structure and stability as a function of distance from the cell surface. Arterioscler Thromb Vasc Biol 2008; 28: 2247-2254.
13. Fatah K, Silveira A, Tornvall P, et al. Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at a young age. Thromb Haemost 1996; 76: 535-540.
14. Jochmans K, Lissens W, Vervoort R, et al. Antithrombin- Gly 424 Arg: a novel point mutation responsible for type 1 antithrombin deficiency and neonatal thrombosis. Blood 1994; 83: 146-151.
15. Kuhle S, Lane DA, Johamanns A, et al. Homozygous antithrombin deficiency type II (99 Leu to Phe mutation) and childhood thromboembolism. Thromb Haemost 2001; 86: 1007-1011.
16. Roldán V, Ordoñez A, Marín F, et al. Antithrombin Cambridge II (A384S) supports a role for antithrombin deficiency in arterial thrombosis. Thromb Haemost 2009; 101: 483-486.